Product Description:
Synthofenac-PG Tablet is a sustained-release oral formulation designed for the management of chronic pain conditions involving both inflammatory and neuropathic components, providing prolonged and consistent pain control.

Composition:
Each tablet contains Aceclofenac SR (200 mg), a non-steroidal anti-inflammatory drug, and Pregabalin SR (75 mg), a neuropathic pain modulator, formulated in sustained-release form to ensure extended therapeutic effect.

Dosage Form:
Sustained-release tablet intended for oral administration, allowing once-daily or as-prescribed dosing for improved patient compliance.

Pharmacological Category:
Combination of NSAID and anticonvulsant/neuropathic analgesic, used in multimodal pain management.

Mechanism of Action:
Aceclofenac inhibits prostaglandin synthesis to reduce pain and inflammation, while Pregabalin modulates calcium channel activity in nerve cells to reduce abnormal nerve signaling associated with neuropathic pain.

Indications / Uses:
Indicated in chronic musculoskeletal pain, neuropathic pain, radiculopathy, sciatica, osteoarthritis-associated pain, and other conditions where inflammation and nerve pain coexist.

Therapeutic Benefits:
Provides effective relief from pain and inflammation, reduces nerve-related symptoms such as burning and tingling, and offers sustained pain control with reduced dosing frequency.

Route of Administration:
Administered orally under medical supervision.

Dosage and Duration:
Dosage and duration of treatment should be determined by a healthcare professional based on the patient’s clinical condition and response to therapy.

Safety Information:
To be used only on prescription; caution is advised in patients with gastrointestinal, renal, or neurological conditions, and the tablet should be swallowed whole without crushing or chewing.

Storage Conditions:
Store in a cool, dry place away from moisture and direct sunlight, and keep out of reach of children.